RCAS1 expression: A potential prognostic marker for adenocarcinomas of the lung

Oncology

Volumn 62, Issue 4, 2002, Pages 333-339

  Oizumi, Satoshi ^a   Yamazaki, Koichi ^a   Nakashima, Manabu ^c   Watanabe, Takeshi ^c   Hommura, Fumihiro ^a   Ogura, Shigeaki ^a   Nishimura, Masaharu ^a   Dosaka Akita, Hirotoshi ^b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Immune escape; Lung adenocarcinoma; Non small cell lung cancer; Prognosis; RCAS1

Indexed keywords

MONOCLONAL ANTIBODY; RCAS1 ANTIGEN; TUMOR ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATHOLOGY; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADENOCARCINOMA; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; CELL DIFFERENTIATION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE;

EID: 0036060626     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065065     Document Type: Article

References (34)

1. Progress in understanding the molecular pathogenesis of human lung cancer
2. Staging and prognostic factors: Non-small cell lung cancer
3. Expression of MAGE genes by non-small-cell lung carcinomas
4. Detection of MAGE-4 protein in lung cancers
5. Selection of tumor antigens as targets for immune attack using immunohistochemistry: Protein antigens
6. Establishment of a new human uterine cervical adenocarcinoma cell line, SiSo, and its reactivity to anti-cancer reagents
7. Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1
8. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas
9. Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias
10. The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix
11. Histological typing of lung tumours, ed 2
12. Lung
13. KIP1 protein and Ki-67 growth fraction in non-small cell lung cancers
14. Prognostic significance of p53 and ras p21 expression in nonsmall cell lung cancer
15. Altered retinoblastoma protein expression in nonsmall cell lung cancer: Its synergistic effects with altered ras and p53 protein status on prognosis
16. Bcl-2 expression in non-small cell lung cancers: Higher frequency of expression in squamous cell carcinomas with earlier pT status
17. Cyclin E expression, a potential prognostic marker for non-small cell lung cancers
18. Immunocytochemical study of transforming growth factor expression in benign and malignant glioma
19. Messenger RNA expression of the immunosuppressive cytokine IL-10 in human gliomas
20. Expression of HLA class I and II antigens in bronchogenic carcinomas: Its relationship to cellular DNA content and clinical-pathological parameters
21. Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer
22. Structural and functional analysis of β2 microglobulin abnormalities in human lung and breast cancer
23. Molecular basis for lack of expression of HLA class I antigens in human small-cell lung carcinoma cell lines
24. A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancer
25. Identification and characterization of a new member of the TNF family that induces apoptosis
26. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family
27. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis
28. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer
29. Fas ligand-induced apoptosis as a mechanism of immune privilege
30. Melanoma cell expression of Fas (Apo-1/CD95) ligand: Implications for tumor immune escape
31. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - A mechanism of immune evasion?
32. Human lung carcinomas express Fas ligand
33. Expression of Fas (CD95/APO-1) and Fas ligand in lung cancer, its prognostic and predictive relevance
34. Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape